‘Pivotal’: London cancer centre reborn with $20-million gift

[ad_1]

The generosity of a late Ingersoll trucking magnate and his widow were saluted Monday as the London Regional Cancer Program was renamed.

Article content

Equipped with a record donation, London’s cancer treatment centre turned a new page Monday with a new name honouring a late Southwestern Ontario entrepreneur who left $20 million to fight the disease that took a terrible toll on his family.

Archie Verspeeten’s son said he hopes that legacy, among the $27 million that his late father and mother donated to London Health Sciences Centre (LHSC) over the years, will one day mean that the London Regional Cancer Program – now renamed the Verspeeten Family Cancer Centre – will never have to treat another patient.

Advertisement 2

Article content

Article content

“I hope they find a cure for cancer,” Dennis Verspeeten said, as the program’s new name was unveiled. 

“That was my dad’s dream. He was so devastated losing two sons. He wanted to go before another one of his sons died because of cancer,” he said.

Dennis Verspeeten
Dennis Verspeeten, son of the late Archie and Irene Verspeeten, speaks at a ceremony to unveil the Verspeeten Family Cancer Centre at London Health Sciences Centre on Monday, April 29, 2024. Archie and Irene Verspeeten donated $20 million to the cancer treatment centre that was formerly called the London Regional Cancer Program. (Beatriz Baleeiro/The London Free Press)

Archie Verspeeten, who built a regional trucking empire from scratch through Ingersoll-based Verspeeten Cartage, made headlines days after his death last fall when the historic gift he left to the cancer centre was announced. Both his widow Irene and sons Ron and Alan died of cancer.

“Dad understood this donation wouldn’t single-handedly eradicate cancer, but he believed it could win a couple battles and maybe contribute to the larger war,” Dennis Verspeeten said. “His greatest wish was for no other family to have to endure the loss we have experienced because of this disease.”

The record donation will transform the centre into “a beacon of innovation and excellence in cancer treatment and research,” the London Health Sciences Foundation, the fundraising arm of LHSC, said Monday as officials broadly detailed how the money will be used.

Advertisement 3

Article content

“Today marks the beginning of the total reimagining of the London Regional Cancer Program,” said John MacFarlane, the foundation’s president and chief executive. “The Verspeeten Family Cancer Centre will ensure we continue pushing the boundaries of cancer care at London Health Sciences Centre, setting new standards for others to follow. This is only made possible by the generosity of selfless donors, like Archie and Irene.”

Half the money will be used to improve patient care at the centre, which serves a large swath of Southwestern Ontario, and to fund cancer research and fellowships for oncology specialists at the centre, whose origins date back to the earliest days of modern cancer care in Ontario.

On the research side, $5 million will be used to establish the Verspeeten Chair in Translational Cancer Research and $3 million to enhance the Verspeeten Clinical Genome Centre. Another $2 million will be used to fund fellowships. 

“The chair position allows recruits to provide salary support to research and help envision what cancer research will look like. The fellowship training offers a subspecialty type of training that allows training for an extra decade,” said MacFarlane.

Advertisement 4

Article content



The Verspeeten donation is “pivotal” to cancer research and treatment, said Dr. Michael Ott, LHSC’s head of oncology.

“This allows us to do more than what we have available,” he said. “We’re already finding treatments that are highly selective (for cancer), and people are living longer, and being cured of their cancer will make that possible for more people, with enough effort and time.”

The donation will also contribute to finishing the work at the genome centre that examines gene expressions in tumours to create specific therapies for specific tumours, which was part of Archie’s original gift to the program, said Ott. 

Kevin Chan, acting president and chief executive of LHSC, said Archie and Irene Verspeeten’s “visonary donation” enables “us to continue our work to improve patient outcomes by advancing excellence in cancer care, teaching and research.”

When he saw the centre’s new name Monday, Dennis Verspeeten said he was buoyed but that his father would have shied away from the publicity.

“When you’re driving in, it makes you feel so happy (to see it),” he said. “My dad would be proud, but he wouldn’t have been here. He was embarrassed by people thinking how much money he had. He just wanted to help people.”

[email protected]

Recommended from Editorial

Article content

Sources

1/ https://Google.com/

2/ https://lfpress.com/news/local-news/london-cancer-centre-renamed-after-archie-verpeeten-donation

The mention sources can contact us to remove/changing this article

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts